Pfizer Builds Upon Robust Body Of Knowledge For XELJANZ With Clinical Trial And Real-World Use Data At The European League Against Rheumatism Annual Congress
June 10, 2015 at 08:09 AM EDT
Pfizer Inc. announced today that more than 20 abstracts including new rheumatoid arthritis (RA) research for XELJANZ® (tofacitinib ...
